Previous studies have demonstrated that sorafenib resistance in HCC is regulated by several signaling pathway, including EGFR signaling, PI3K/AKT pathway, autophagy and Epithelial-mesenchymal transition (EMT) [4]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.